Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yao Zhu
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
ORCID:
0000-0001-7950-6669
Observed ORCID:
0000-0001-7950-6669
OpenAlex ID:
A5127910367
Real-world effectiveness and safety of radium-223 therapy in castration-resistant prostate cancer with bone metastases
2026
·
Hong-Kai Wang
, Zhen Hang
, et al.
·
Asian Journal of Andrology
·
1
Consolidative therapy for PSMA-avid lesions after 3 cycles of apalutamide plus androgen deprivation in metastatic hormone-sensitive prostate cancer: A prospective phase 2 single-arm trial
2026
·
Jian Pan
, Beihe Wang
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
Impact of lead-in ADT on grade ≥3 neutropenia in patients with metastatic hormone-sensitive prostate cancer treated with triplet therapy
2026
·
Xudong Ni
, Yufan Zhao
, et al.
·
Med
Evolving therapies, persistent gaps: a real-world look at survival trends in metastatic prostate cancer
2026
·
Yufan Zhao
, Xudong Ni
, et al.
·
Prostate Cancer and Prostatic Diseases
PDF
Show more works
View as search
Works count:
5
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type